15.01.2013
- AstraZeneca's new chief executive stamped his authority on the struggling drugmaker on Tuesday by removing the heads of research and commercial operations. Pascal Soriot, who took...
15.01.2013
- The Bio-Process Systems Alliance (BPSA) is pleased to announce it has elected five Executive Board members who will serve in leadership positions through December 31, 2015, to...
09.01.2013
- BioMarin Pharmaceutical, which makes high-priced drugs used to treat rare diseases, would not consider a buy-out offer for even a 25-30% premium, according to the company's chief...
08.01.2013
- Hookipa Biotech, a vaccine biotech start up pioneering a new class of vaccines, today announced the appointment of two new members to its management team: Thomas P. Monath as Chief...
07.01.2013
- Sanofi is pleased to announce today the appointment of Dr. Gary J. Nabel, M.D., Ph.D., to Chairman of the Strategic Development and Scientific Advisory Council (SDSAC). Dr. Nabel...
03.01.2013
- Rare diseases are a growing focus for drug companies, with prices for some treatments for ultra-rare conditions running into hundreds of thousands of dollars a year. The following...
03.01.2013
- The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...
02.01.2013
- U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to...
19.12.2012
- The number of new medicines approved or pending approval is on the rise on both sides of the Atlantic, painting an encouraging picture for the global drugs industry as it emerges...
18.12.2012
- European regulators recommended against approval of Sanofi and Isis Pharmaceutical's Kynamro drug for treatment of a rare genetic disorder that causes unusually high cholesterol...
